Medical Toxicology Expert Witnesses in New Mexico

This expert has experience with toxic environmental contamination, industrial chemical exposures and occupational health. this expert is a physician (The Ohio State University), board certified in Occupational Medicine (American Board of Preventive Medicine), who holds a Doctor of Philosophy degree in Toxicology (University of Cincinnati, Kettering Laboratory). He has served on the faculty of the University of Cincinnati and the New York University Medical Center and joined the faculty of the University of Texas School of Public Health in 1992 in its Environmental Sciences Discipline and Occupational and Environmental Health and Aerospace Medicine Module. He is Associate Professor of Occupational Health, directs the Occupational and Environmental Medicine Residency Program and is a member of the research team for an education and research center. He is a graduate of the Health Educators Fellowship and serves as a member of the Center for Interprofessional Collaboration, Steering Committee. He maintains a clinical practice of occupational medicine and medical toxicology and is a frequent consultant to governments, corporations and the legal community on matters related to industrial chemical exposure, toxicology and environmental justice. His research interests include: environmental and occupational chemical exposures, inhalation injuries, the relationship between metal exposures and cancer, and professional training and learning. As a teacher, he specializes in reducing complex subjects to familiar and recognizable concepts that are accessible to a broadly diverse audience.

This highly qualified psychiatric pharmacology expert received a BS in Bacteriology from the Univeristy of California Los Angeles (UCLA) and earned his doctor of pharmacy (Pharm.D.) at the University of Southern California (USC). He had a National Institute of Mental Health (NMH) training fellowship in Psychiatric Pharmacy at the University of Nebraska Medical Center in Omaha, and was recruited to join the faculty of the highly-ranked The University of Texas at Austin College of Pharmacy. He is Board Certified in Psychiatric Pharmacy (BCPP) by the Board of Pharmaceutical Specialties. He serves on the Board of Directors for the College of Psychiatric and Neurologic Pharmacists Foundation and is a founding member of the College of Psychiatric and Neurologic Pharmacists (CPNP). During his 37 years career, this expert has provided clinical care and education in a variety of settings and treatment roles. He teaches didactic and experiential courses for Pharm.D. students and graduate courses for MS and PhD post-Pharm.D. students. He authored and successfully discussed with members of the Texas Legislature the creation of a clinical research unit at San Antonio State Hospital (SASH) that was funded by the Texas Legislature and jointly governed by the UT Austin College of Pharmacy, UT Health Science Center San Antonio Department of Psychiatry and SASH. This expert continues to publish scholarly articles and is regularly invited to do scholarly and lay presentations around the country on a variety of pharmacy and mental health related topics. He was the Senior Founding Editor for a major mental health publication. He edited Psychopharmacology Update newsletter from 1998-2002, and edited two editions of a compendium based upon this newsletter, Psychopharmacology Desktop Reference, published by Manisses Communications Group in 1999 and 2002. He has received several awards reflecting his accomplishments as a clinician, teacher, and researcher.

This highly qualified expert earned his BS from George Fox University and PhD from University of California- Los Angeles. He completed a postdoctoral fellowship at The Scripps Research Institute. He is actively involved in research and education; to date he has 60+ original peer reviewed articles/ abstracts. Currently, he is an Assistant Professor of Pharmacology at a major university affiliated medical center. He has been trained in the study of drug discovery and taught on Molecular Pharmacology, Drug Discovery, Molecular Signaling/Transduction for the past few years at two medical schools. His research work includes collaborations with discovery teams to design new drug strategies, synthesize novel drugs, evaluate them in cell culture models, then evaluate their efficacy, side effect profiles, pharmacokinetics, and toxicology in animal models, all with the goal of developing new drugs for human treatment. Most of his research and drug development work is centered on developing new opioid and cannabinoid drugs for chronic pain, cancer treatment, and similar diseases.

This qualified expert of Electron microscopy completed his education in Germany and a post-doctoral fellowship in Biochemistry in Switzerland. He is a member of the Microscopy Society of America, FRMS, Materials Research Society, Microanalysis Society, ASBMB, TMS, ACS and has 100+ Publications in the area Biochemistry and Structural Biology/Medicine. He is currently a Professor of Biomedical Sciences in the School of Medicine at a prominent University in Texas.

This highly qualified expert has 25 years of experience in pharmacotherapy. He earned both his BS in pharmacy and his PharmD from the University of Missouri. He then completed a clinical pharmacy residency at Truman Medical Center. He is board-certified in pharmacotherapy and a certified geriatric pharmacist. He is active in his field as a member of organizations such as the American Association of Colleges of Pharmacy and the American Society of Consultant Pharmacists. He is also highly involved in pharmacological research, having authored numerous journal articles. His former positions include director of the New Mexico Geriatric Education Center, director of the Center for Pharmaceutical Care for the Elderly at the University of Houston, and director of the Institute for Geriatric Pharmacy at the University of Oklahoma Health Sciences Center. Currently, this expert serves as professor emeritus at a pharmacy college in Oklahoma, as well as the managing partner of a consultancy in Oklahoma.

This expert earned his BS in health and exercise science and his MS in toxicology from Colorado State University and his MS in health services administration with a concentration in biopharmaceutical regulatory compliance and his PharmD from the University of Wyoming. He is active in his field as a member of the National Community Pharmacists Association and the American Pharmacist Association. He formerly served as a pharmacy intern and the flu clinic supervisor for the student health pharmacy at the University of Wyoming. Currently, this expert is a medical content writer for a medical consulting firm.

This expert has over 30 years of experience working in the toxicology and health risk assessment field. He specializes in evaluating potential human health effects of chemical and microbial agent exposures. In particular, he has experience with evaluation of exposures to asbestos, benzene, carbon monoxide, silica, metals, pesticides, solvents, oil and gas fracking chemicals, other petroleum products, and toxic gases. Additionally, he is a Board-Certified Toxicologist as a Diplomate of the American Board of Toxicology and a Licensed Professional Engineer. Currently, this expert is a toxicologist at a privately owned toxicology and human health risk assessment firm.

This expert is a pharmacist and a pharmacologist and a former professor at Yale University and Georgetown University. He is also a former FDA Medical Officer/Senior Medical Analyst, who is an expert in the areas of drug Safety, drug development, regulatory affairs and FDA policy. He as also served as an advisor on the 2016 Ted Cruz presidential campaign, and has also been invited to testify in front of the U.S. Senate as a healthcare policy expert, FDA expert and Pharmacology expert. He has authored or co-authored over 50 publications, papers, articles, reviews, clinical protocols and reports in many related areas including FDA law, drug pricing, healthcare policy, healthcare insurance, drug development and drug patent law.